Aspen Pharmacare was due to release the first 1.1-million doses of the Johnson & Johnson's (J&J) coronavirus vaccine for the South African market this weekend, coinciding with the resumption of the vaccine rollout after it was temporarily halted.

Stavros Nicolaou, Aspen's senior executive for strategic trade, this week confirmed the first 1.1-million doses that were due for release on 24 April will be for SA...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now